title: Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte.
abstract: Proinflammatory oxidized phospholipids are generated during oxidative modification of low-density lipoproteins (LDL). The production of these proinflammatory oxidized phospholipids is controlled by secreted enzymes that circulate as proteins complexed with LDL and high-density lipoprotein. During the acute phase response to tissue injury, profound changes occur in lipoprotein enzymatic composition that alter their anti-inflammatory function. Monocytes may encounter oxidized phospholipids in vivo during their differentiation to macrophages or dendritic cells (DC). In this study we show that the presence of oxidized LDL (oxLDL) at the first day of monocyte differentiation to DC in vitro yielded phenotypically atypical cells with some functional characteristics of mature DC. Addition of oxLDL during the late stage of monocyte differentiation gave rise directly to phenotypically mature DC with reduced uptake capacity, secreting IL-12 but not IL-10, and supporting both syngeneic and allogeneic T cell stimulation. In contrast to known mediators of DC activation, oxLDL did not trigger maturation of immature DC. An intriguing possibility is that a burst of oxidized phospholipids is an endogenous activation signal for the immune system, which is tightly controlled by lipoproteins during the acute phase response.
authors.affiliation: Centre Européen de Recherche en Virologie et Immunologie, Institut National de la Santé et de la Recherche Médicale, 21 Avenue Tony Garnier, F-69007 Lyon, France.
authors.forename: L
authors.initials: L
authors.lastname: Perrin-Cocon
authors.forename: F
authors.initials: F
authors.lastname: Coutant
authors.forename: S
authors.initials: S
authors.lastname: Agaugué
authors.forename: S
authors.initials: S
authors.lastname: Deforges
authors.forename: P
authors.initials: P
authors.lastname: André
authors.forename: V
authors.initials: V
authors.lastname: Lotteau
mesh_terms: D002454:Cell Differentiation; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D004705:Endocytosis; D006801:Humans; D016130:Immunophenotyping; D007519:Isoantigens / Q000276:immunology; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D008213:Lymphocyte Activation; D009000:Monocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D018123:Receptors, Interleukin / Q000096:biosynthesis; D053707:Receptors, Interleukin-12; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D007519:Isoantigens; D008077:Lipoproteins, LDL; D018123:Receptors, Interleukin; D053707:Receptors, Interleukin-12; C099252:oxidized low density lipoprotein